5-HT1B-receptor (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "5-HT1B-receptor" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

19nih.gov

4^th place

11^th place

14doi.org

2^nd place

8^th place

3archive.org

6^th place

14^th place

1genecards.org

low place

archive.org

Hoyer D, Hannon JP, Martin GR (2002. április 1.). „Molecular, pharmacological and functional diversity of 5-HT receptors”. Pharmacology Biochemistry and Behavior 71 (4), 533–54. o. DOI:10.1016/S0091-3057(01)00746-8. PMID 11888546.
Hudzik TJ, Yanek M, Porrey T, Evenden J, Paronis C, Mastrangelo M, Ryan C, Ross S, Stenfors C (2003. március 1.). „Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist”. The Journal of Pharmacology and Experimental Therapeutics 304 (3), 1072–84. o. DOI:10.1124/jpet.102.045468. PMID 12604684.
Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW (1998. szeptember 1.). „SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity”. British Journal of Pharmacology 125 (1), 202–8. o. DOI:10.1038/sj.bjp.0702059. PMID 9776361. PMC 1565605.

doi.org

dx.doi.org

Jin H, Oksenberg D, Ashkenazi A, Peroutka SJ, Duncan AM, Rozmahel R, Yang Y, Mengod G, Palacios JM, O'Dowd BF (1992. március 1.). „Characterization of the human 5-hydroxytryptamine1B receptor”. The Journal of Biological Chemistry 267 (9), 5735–8. o. DOI:10.1016/S0021-9258(18)42612-9. PMID 1348246.
Sanders AR, Cao Q, Taylor J, Levin TE, Badner JA, Cravchik A, Comeron JM, Naruya S, Del Rosario A, Salvi DA, Walczyk KA, Mowry BJ, Levinson DF, Crowe RR, Silverman JM, Gejman PV (2001. február 1.). „Genetic diversity of the human serotonin receptor 1B (HTR1B) gene”. Genomics 72 (1), 1–14. o. DOI:10.1006/geno.2000.6411. PMID 11247661.
Pytliak M, Vargová V, Mechírová V, Felšöci M (2011). „Serotonin receptors - from molecular biology to clinical applications”. Physiological Research 60 (1), 15–25. o. DOI:10.33549/physiolres.931903. PMID 20945968.
Huang CC, Yeh CM, Wu MY, Hsu KS (2013. június 1.). „A single in vivo cocaine administration impairs 5-HT(1B) receptor-induced long-term depression in the nucleus accumbens”. Journal of Neurochemistry 125 (6), 809–821. o. DOI:10.1111/jnc.12227. PMID 23452061.
Cai X, Kallarackal AJ, Kvarta MD, Goluskin S, Gaylor K, Bailey AM, Lee HK, Huganir RL, Thompson SM (2013. április 1.). „Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression”. Nature Neuroscience 16 (4), 464–72. o. DOI:10.1038/nn.3355. PMID 23502536. PMC 3609911.
Shoval G, Bar-Shira O, Zalsman G, John Mann J, Chechik G (2014. július 1.). „Transitions in the transcriptome of the serotonergic and dopaminergic systems in the human brain during adolescence”. European Neuropsychopharmacology 24 (7), 1123–32. o. DOI:10.1016/j.euroneuro.2014.02.009. PMID 24721318.
Tepper, S. J. (2002). „Mechanisms of action of the 5-HT1B/1D receptor agonists”. Archives of Neurology 59 (7), 1084–1088. o. DOI:10.1001/archneur.59.7.1084. PMID 12117355.
Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G (2008. november 1.). „Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum”. Cell 135 (5), 825–37. o. DOI:10.1016/j.cell.2008.09.059. PMID 19041748. PMC 2614332.
Hoyer D, Hannon JP, Martin GR (2002. április 1.). „Molecular, pharmacological and functional diversity of 5-HT receptors”. Pharmacology Biochemistry and Behavior 71 (4), 533–54. o. DOI:10.1016/S0091-3057(01)00746-8. PMID 11888546.
Hudzik TJ, Yanek M, Porrey T, Evenden J, Paronis C, Mastrangelo M, Ryan C, Ross S, Stenfors C (2003. március 1.). „Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist”. The Journal of Pharmacology and Experimental Therapeutics 304 (3), 1072–84. o. DOI:10.1124/jpet.102.045468. PMID 12604684.
Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW (1998. szeptember 1.). „SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity”. British Journal of Pharmacology 125 (1), 202–8. o. DOI:10.1038/sj.bjp.0702059. PMID 9776361. PMC 1565605.
Roberts C, Watson J, Price GW, Middlemiss DN (2001). „SB-236057-A: a selective 5-HT1B receptor inverse agonist”. CNS Drug Reviews 7 (4), 433–44. o. DOI:10.1111/j.1527-3458.2001.tb00209.x. PMID 11830759. PMC 6741665.
Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR (2016). „Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders”. Pharmacol. Ther. 159, 1–22. o. DOI:10.1016/j.pharmthera.2016.01.016. PMID 26826604.
Tsai SJ, Wang YC, Chen JY, Hong CJ (2003). „Allelic variants of the tryptophan hydroxylase (A218C) and serotonin 1B receptor (A-161T) and personality traits”. Neuropsychobiology 48 (2), 68–71. o. DOI:10.1159/000072879. PMID 14504413.

genecards.org

5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled. (Hozzáférés: 2013. február 23.)

nih.gov

pubmed.ncbi.nlm.nih.gov

Jin H, Oksenberg D, Ashkenazi A, Peroutka SJ, Duncan AM, Rozmahel R, Yang Y, Mengod G, Palacios JM, O'Dowd BF (1992. március 1.). „Characterization of the human 5-hydroxytryptamine1B receptor”. The Journal of Biological Chemistry 267 (9), 5735–8. o. DOI:10.1016/S0021-9258(18)42612-9. PMID 1348246.
Sanders AR, Cao Q, Taylor J, Levin TE, Badner JA, Cravchik A, Comeron JM, Naruya S, Del Rosario A, Salvi DA, Walczyk KA, Mowry BJ, Levinson DF, Crowe RR, Silverman JM, Gejman PV (2001. február 1.). „Genetic diversity of the human serotonin receptor 1B (HTR1B) gene”. Genomics 72 (1), 1–14. o. DOI:10.1006/geno.2000.6411. PMID 11247661.
Pytliak M, Vargová V, Mechírová V, Felšöci M (2011). „Serotonin receptors - from molecular biology to clinical applications”. Physiological Research 60 (1), 15–25. o. DOI:10.33549/physiolres.931903. PMID 20945968.
Huang CC, Yeh CM, Wu MY, Hsu KS (2013. június 1.). „A single in vivo cocaine administration impairs 5-HT(1B) receptor-induced long-term depression in the nucleus accumbens”. Journal of Neurochemistry 125 (6), 809–821. o. DOI:10.1111/jnc.12227. PMID 23452061.
Cai X, Kallarackal AJ, Kvarta MD, Goluskin S, Gaylor K, Bailey AM, Lee HK, Huganir RL, Thompson SM (2013. április 1.). „Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression”. Nature Neuroscience 16 (4), 464–72. o. DOI:10.1038/nn.3355. PMID 23502536. PMC 3609911.
Shoval G, Bar-Shira O, Zalsman G, John Mann J, Chechik G (2014. július 1.). „Transitions in the transcriptome of the serotonergic and dopaminergic systems in the human brain during adolescence”. European Neuropsychopharmacology 24 (7), 1123–32. o. DOI:10.1016/j.euroneuro.2014.02.009. PMID 24721318.
Tepper, S. J. (2002). „Mechanisms of action of the 5-HT1B/1D receptor agonists”. Archives of Neurology 59 (7), 1084–1088. o. DOI:10.1001/archneur.59.7.1084. PMID 12117355.
Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G (2008. november 1.). „Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum”. Cell 135 (5), 825–37. o. DOI:10.1016/j.cell.2008.09.059. PMID 19041748. PMC 2614332.
Hoyer D, Hannon JP, Martin GR (2002. április 1.). „Molecular, pharmacological and functional diversity of 5-HT receptors”. Pharmacology Biochemistry and Behavior 71 (4), 533–54. o. DOI:10.1016/S0091-3057(01)00746-8. PMID 11888546.
Hudzik TJ, Yanek M, Porrey T, Evenden J, Paronis C, Mastrangelo M, Ryan C, Ross S, Stenfors C (2003. március 1.). „Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist”. The Journal of Pharmacology and Experimental Therapeutics 304 (3), 1072–84. o. DOI:10.1124/jpet.102.045468. PMID 12604684.
Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW (1998. szeptember 1.). „SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity”. British Journal of Pharmacology 125 (1), 202–8. o. DOI:10.1038/sj.bjp.0702059. PMID 9776361. PMC 1565605.
Roberts C, Watson J, Price GW, Middlemiss DN (2001). „SB-236057-A: a selective 5-HT1B receptor inverse agonist”. CNS Drug Reviews 7 (4), 433–44. o. DOI:10.1111/j.1527-3458.2001.tb00209.x. PMID 11830759. PMC 6741665.
Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR (2016). „Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders”. Pharmacol. Ther. 159, 1–22. o. DOI:10.1016/j.pharmthera.2016.01.016. PMID 26826604.
Tsai SJ, Wang YC, Chen JY, Hong CJ (2003). „Allelic variants of the tryptophan hydroxylase (A218C) and serotonin 1B receptor (A-161T) and personality traits”. Neuropsychobiology 48 (2), 68–71. o. DOI:10.1159/000072879. PMID 14504413.

ncbi.nlm.nih.gov

Entrez Gene: HTR1B 5-hydroxytryptamine (serotonin) receptor 1B
Cai X, Kallarackal AJ, Kvarta MD, Goluskin S, Gaylor K, Bailey AM, Lee HK, Huganir RL, Thompson SM (2013. április 1.). „Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression”. Nature Neuroscience 16 (4), 464–72. o. DOI:10.1038/nn.3355. PMID 23502536. PMC 3609911.
Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G (2008. november 1.). „Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum”. Cell 135 (5), 825–37. o. DOI:10.1016/j.cell.2008.09.059. PMID 19041748. PMC 2614332.
Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW (1998. szeptember 1.). „SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity”. British Journal of Pharmacology 125 (1), 202–8. o. DOI:10.1038/sj.bjp.0702059. PMID 9776361. PMC 1565605.
Roberts C, Watson J, Price GW, Middlemiss DN (2001). „SB-236057-A: a selective 5-HT1B receptor inverse agonist”. CNS Drug Reviews 7 (4), 433–44. o. DOI:10.1111/j.1527-3458.2001.tb00209.x. PMID 11830759. PMC 6741665.